The people powering British Patient Capital
Keith Morgan led the set-up of the British Business Bank from January 2013 and was appointed CEO in December 2013.
Prior to this, Keith was an Executive Director of UK Financial Investments (UKFI), joining in 2009 to manage the UK Government’s shareholdings in Bradford & Bingley and Northern Rock.
Keith joined UKFI from Banco Santander where he was an Executive Director of its US business and before that an Executive Committee member of Abbey National. Prior to joining Abbey in 2004, Keith spent 17 years at L.E.K. Consulting, where he was a partner specialising in financial services.
Keith is a Non-Executive Director of UK Asset Resolution and a Trustee of the Design Council. He holds an MA in Philosophy, Politics and Economics from University College, Oxford and an MBA from Harvard Business School.
Catherine Lewis La Torre
Catherine joined the British Business Bank Group in 2016 when she was appointed CEO of British Business Investments, the Bank’s commercial arm engaged primarily in direct lending strategies. In October 2018 Catherine took on the additional role as CEO of British Patient Capital, a recently established commercial subsidiary with a mandate to make long term equity investments in high growth businesses in the UK.
She was previously Head of Private Equity at Cardano Risk Management where she was responsible for managing a global portfolio of private capital investments with in excess of £1 billion of committed capital. Prior to this she was Managing Director with secondaries specialist, Fondinvest Capital, in Paris.
Catherine was one of the Founding Partners of Nordic fund-of-funds manager, Proventure and subsequently launched her own consulting business advising institutional investors in the US and Asia on their European private capital strategies. Catherine began her career as an Analyst with Venture Economics, now part of Thomson Reuters, before joining Cinven, a European Private Equity group, as an Investment Manager.
She holds a B.Sc. (Econ.) from the London School of Economics where she graduated with First Class Honours.
Russ Cummings joined British Patient Capital as an independent Non-Executive Director in June 2018.
Russ is the former Chief Executive Officer of Touchstone Innovations plc, one of the UK’s leading technology investment companies, championing outstanding science by commercialising innovative research from UK universities. Russ joined as Chief Investment Officer in 2006, then became CEO in 2013 through to the acquisition of Touchstone in 2017 by IP Group plc for £500m.
From 2003 to 2006, he was a director at the growth equity and venture capital firm, Scottish Equity Partners LLP and prior to this, spent 16 years at the international venture capital and private equity company, 3i Group plc, latterly as Director in its UK Technology Group. Russ is also a Non-Executive Director of Circassia Pharmaceuticals plc.
He holds a BSc(Eng) in Mechanical Engineering from Imperial College, London.
Anu joined the investment team at British Patient Capital in June 2018, after transferring from the Venture Capital Solutions team at the British Business Bank, working on both Enterprise Capital Fund and Venture Catalyst transactions.
Anu joined the predecessor of British Business Bank, Capital for Enterprise Limited, in 2012 as part of the Angel CoFund where she made direct investments alongside angel syndicates. There, she worked on over 40 deals into largely early stage, high growth companies. She has a background in finance, in a variety of roles including 18 months in Nigeria at pan-African bank, Ecobank. Prior to this, Anu ran an award winning ecommerce startup.
Natalie is a Director at British Patient Capital. She joined BPC in 2018 from the Private Equity team at Aberdeen Standard Investments.
Prior to this, Natalie worked in the investment team at SVG Advisers, a subsidiary of SVG Capital. Natalie brings more than a decade of experience in the private equity market, having worked on both primary and secondary investments in buyout and venture capital funds across Europe, as well as managing fund vehicles across a number of jurisdictions. Natalie started her career as a management consultant focused on business transformation at Corven and Andersen.
She holds a degree from University of Oxford and is a Fellow of the Institute of Chartered Accountants on England and Wales.
Managing Director, Funds
Ian manages the Funds activity of British Patient Capital. He is responsible for developing British Patient Capital’s investment strategy and investment process, as well as supervising all investment transactions – especially at the advanced due diligence stage and legal completion.
Ian joined British Patient Capital from the British Business Bank, which he joined at its formation in late 2014. Prior to that, he was part of the Bank’s predecessor, Capital for Enterprise Ltd. He brings with him a wealth of experience, including close involvement in the development of the Venture Capital Catalyst and Enterprise Capital Funds portfolios which have invested in 41 funds to date, facilitating more than £1bn of investment in over 400 smaller businesses. He previously worked in corporate finance at technology company Infinity SDC and in financial modelling at the Royal Bank of Scotland.
Investment AnalystPinky joined BPC 2018, as an analyst focusing on operations, and supporting the team on new deals. Pinky has worked as an investment research analyst and has a broad range of experience in equity research, business analysis and financial content development for the Indian and the U.S. equity markets.
Senior Investment Manager
Rob is a Senior Investment Manager at British Patient Capital with responsibility for leading and managing investments in venture and growth capital funds, including completion of British Patient Capital’s first listed investment. He joined British Patient Capital from the British Business Bank where he worked since its formation in late 2014, transitioning from the debt to equity team in March 2017. Prior to that Rob was part of the Bank’s predecessor, Capital for Enterprise Ltd, where he was involved with the design and implementation of various debt related programmes.
Rob has extensive transaction execution and portfolio management experience, having previously spent 12 years in corporate and commercial banking with Clydesdale Bank. There he held various relationship management, project management and credit risk roles.
Christine is a Director in the recently formed British Patient Capital, a subsidiary of the British Business Bank.
She joined the British Business Bank in 2014 and has been part of the Venture Solutions team, where she was involved in investing the VC Catalyst programme and delivering the Enterprise Capital Fund programme; and, the British Business Investments team, where she focussed on equity funds. She has an investment, corporate finance and commercial background having worked at Bank of Scotland, PwC and BOC Industrial Gases.
Investment ManagerRichard joined the British Business Bank in 2016 and transitioned to British Patient Capital at its formation in 2018. To date Richard has facilitated commitments of more than £140 million in fundraisings exceeding £380 million into the venture capital funds of Episode 1, FPE, Imbiba, Draper Esprit, and Crane. Prior to joining the bank Richard previously held roles in the actuarial sector, at a risk arbitrage fund, in foreign currency banking, and at a FinTech start up.
Senior Investment Manager
Tej is a Senior Investment Manager within British Patient Capital having joined British Business Bank in mid-2017. Previously as part of the Venture Solutions team at the bank, he led a number of investments into Technology and Life Sciences focused Venture Capital Funds, including the Dementia Discovery Fund.
He formerly held roles as Head of Credit and Equity Risk at Crowdcube and was CEO of a real estate fund based in Poland for over a decade. Tej began his career in Citigroup as a corporate banker before working with 2 fintech startups and a boutique corporate advisory firm focused on LBO transactions.
Senior Investment Manager
Chris joined the investment team at British Patient Capital in June 2018, after transferring from the Venture Capital Solutions team at the British Business Bank.
Chris joined British Business Bank in 2015 as a Senior Manager, Financial Risk, and lead for the Bank’s equity programmes before moving to the Venture Capital Solutions Funds team as a Senior Investment Manager in 2017. Prior to joining the Bank, Chris held roles in Sponsor Coverage, providing banking products and services to mid-market buyout funds; Structured Finance; Industrials Coverage; and Corporate Banking.